Who are local tetracycline's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): ActiveMatrix.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/local-tetracycline.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

local tetracycline — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

local tetracycline (local tetracycline) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Matrix metalloproteinase inhibitor. Area: Dentistry / Periodontics.

phase 3 Matrix metalloproteinase inhibitor Matrix metalloproteinases (MMPs) Dentistry / Periodontics Small molecule Live · refreshed every 30 min

Target snapshot

local tetracycline (local tetracycline) — The Forsyth Institute. Local tetracycline delivery inhibits matrix metalloproteinases and reduces inflammation in periodontal tissues.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
local tetracycline TARGET	local tetracycline	The Forsyth Institute	phase 3	Matrix metalloproteinase inhibitor	Matrix metalloproteinases (MMPs)
ActiveMatrix	ActiveMatrix	Baylor College of Medicine	marketed	matrix metalloproteinase inhibitor	matrix metalloproteinases

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Matrix metalloproteinase inhibitor class)

The Forsyth Institute · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). local tetracycline — Competitive Intelligence Brief. https://druglandscape.com/ci/local-tetracycline. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing